Trial intelligence / Profile preview

Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform

NCT04777006Phase 4Completed

Sponsor
RanD
Start
Sep 2021
Primary completion
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fluoxetine, amitriptyline in major depressive disorder (MDD), sponsored by RanD. Started Sep 2021; status: completed.

02

Drugs

fluoxetineamitriptyline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT04777006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04777006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call